ANA ROSA CELAYA: Open Payments
NPI 1306044243 · LINDSAY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 48 payments from 9 companies in 2025. Trend: 2023 $1,319 · 2024 $1,956 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $217 |
| Amgen Inc. | 20 | $154 |
| Novo Nordisk Inc | 6 | $147 |
| Phathom Pharmaceuticals, Inc. | 5 | $71 |
| ANI Pharmaceuticals, Inc. | 3 | $53 |
| Antares Pharma, Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: ZEPBOUND, Wegovy, TEZSPIRE, VOQUEZNA, OTEZLA, PURIFIED CORTROPHIN GEL, MOUNJARO, XYOSTED.
Industry payments across CA — which companies pay providers there.
